Jones Financial Companies’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $292K | Buy |
1,196
+460
| +63% | +$112K | ﹤0.01% | 1502 |
|
|
2025
Q1 | $179K | Buy |
736
+332
| +82% | +$80.7K | ﹤0.01% | 1533 |
|
|
2024
Q4 | $133K | Buy |
404
+371
| +1,124% | +$122K | ﹤0.01% | 1521 |
|
|
2024
Q3 | $11K | Buy |
33
+19
| +136% | +$6.31K | ﹤0.01% | 2181 |
|
|
2024
Q2 | $3.82K | Buy |
+14
| New | +$3.82K | ﹤0.01% | 2005 |
|
|
2024
Q1 | – | Sell |
-8
| Closed | -$2.58K | – | 1371 |
|
|
2023
Q4 | $2.58K | Buy |
8
+7
| +700% | +$2.26K | ﹤0.01% | 877 |
|
|
2023
Q3 | $358 | Buy |
+1
| New | +$358 | ﹤0.01% | 675 |
|
|
2022
Q3 | – | Sell |
-2
| Closed | -$1K | – | 550 |
|
|
2022
Q2 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 616 |
|
|
2021
Q1 | – | Sell |
-22
| Closed | -$13K | – | 783 |
|
|
2020
Q4 | $13K | Buy |
+22
| New | +$13K | ﹤0.01% | 405 |
|